Ask Michael Burke Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Knighty Tin who wrote (119019)	7/28/2009 1:44:11 PM
From: Pogeu Mahone	Read Replies (1) of 132070

Drug development made easy like giving candy to a baby: Blue M&Ms 'mend spinal injuries' The food dye that gives blue M&Ms their colour can help mend spinal injuries, researchers have claimed after tests on rats. Published: 7:00AM BST 28 Jul 2009 On the downside, the treatment causes the skin to temporarily turn bright blue and BBG needs to be injected soon after the trauma The compound Brilliant Blue G blocks a chemical that kills healthy spinal cord cells around the damaged area - an event that often causes more irreversible damage than the original injury. BBG not only reduced the size of the lesion but also improved the recovery of motor skills, the rodent tests showed. Related Articles Half a pint of milk in childhood linked to lower stroke risk Wasp hordes poised to invade British gardens First animals 'from lakes not sea' Rural broadband 'a third slower' Bacon sandwich really does cure a hangover Eating crusts 'protects against bowel cancer'Those treated with BBG were later able to walk, although with a limp. Rats that did not receive the BBG solution never regained the ability to walk. On the downside, the treatment causes the skin to temporarily turn bright blue and BBG needs to be injected soon after the trauma. The test injections were given within 15 minutes. The new findings by researchers at the University of Rochester Medical Centre in New York build on work reported five years ago by the same team. They discovered that adenosine triphosphate (ATP) - a chemical that keeps our cells alive - quickly pours into the area surrounding a spinal cord injury. But they found it overstimulated otherwise healthy neurons and caused them to die from metabolic stress, creating a secondary injury. Injecting oxidised ATP into the site of the injury helped stop this, they found. But neurosurgeon Prof Maiken Nedergaard, who led the research, said: "No one wants to put a needle into a spinal cord that has just been severely injured so we knew we needed another way." The new approach of using BBG has answered this problem because it can be administered intravenously. More tests will be needed to prove the safety of BBG before human clinical trials can begin. But researchers are optimistic new treatments for acute spinal cord injuries could emerge in the next few years. Text Size Email this article Print this article Share this article delicious telegraph.co.uk Science News Get feed updatesNews Get feed updatesFood and Drink News Get feed updatesHealth News Get feed updates More on Science News Get feed updates

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next